Latest Articles

  • Personalizing patient care
    Kathryn A. Teng, MD and Charis Eng, MD, PhD
    Cleveland Clinic Journal of Medicine May 2012, 79 (5) 329-330; DOI: https://doi.org/10.3949/ccjm.79a.11074

    Personalized health care has been anticipated for decades. Yet in its breadth and in the way we would like it to be practiced, it is still in its infancy.

  • Lung cancer screening: Examining the issues
    Peter Mazzone, MD, MPH
    Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S1-S6; DOI: https://doi.org/10.3949/ccjm.79.s2.01
  • Lung cancer screening: What to expect
    Cleveland Clinic Journal of Medicine May 2012, 79 (5) 346;
  • The role of adjuvant chemotherapy in early-stage and locally advanced non–small cell lung cancer
    Marc Shapiro, MD
    Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S42-S45; DOI: https://doi.org/10.3949/ccjm.79.s2.09
  • Hyperpigmentation and hypotension
    Khaldoon Shaheen, MD, Abdul Hamid Alraiyes, MD, Motaz Baibars, MD and M. Chadi Alraies, MD, FACP
    Cleveland Clinic Journal of Medicine May 2012, 79 (5) 308-312; DOI: https://doi.org/10.3949/ccjm.79a.10187

    A 65-year-old man presents after 2 months of weakness, dizziness, and blurred vision. What test should be ordered?

  • Personalized targeted therapy in advanced non–small cell lung cancer
    Patrick C. Ma, MD, MS
    Cleveland Clinic Journal of Medicine May 2012, 79 (5 e-suppl 1) S56-S60; DOI: https://doi.org/10.3949/ccjm.79.s2.12
  • In Reply: Essential tremor, beta-blockers, and calcium channel blockers (December 2011)
    Hesham Abboud, MD, Anwar Ahmed, MD and Hubert H. Fernandez, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 242; DOI: https://doi.org/10.3949/ccjm.79c:04005

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Glucocorticoid-induced diabetes and adrenal suppression (November 2011)
    David L. Keller, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 236-237; DOI: https://doi.org/10.3949/ccjm.79c.04002

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • Factor V Leiden: How great is the risk of venous thromboembolism?
    Khaldoon Shaheen, MD, M. Chadi Alraies, MD, FACP, Abdul Hamid Alraiyes, MD and Richard Christie, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 265-272; DOI: https://doi.org/10.3949/ccjm.79a.11072

    The risk of a first episode of thromboembolism is two to five times higher with the heterozygous factor V Leiden mutation, but the absolute risk is still low.

  • In Reply: Glucocorticoid-induced diabetes and adrenal suppression (November 2011)
    M. Cecilia Lansang, MD, MPH and Leighanne Kramer Hustak, DNP, BC-FNP, CDE
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 237-242; DOI: https://doi.org/10.3949/ccjm.79c.04003

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

Pages